Engineering & Construction
Compare Stocks
4 / 10Stock Comparison
AMRC vs PESI vs ERII vs GEVO
Revenue, margins, valuation, and 5-year total return — side by side.
Waste Management
Industrial - Pollution & Treatment Controls
Chemicals - Specialty
AMRC vs PESI vs ERII vs GEVO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Engineering & Construction | Waste Management | Industrial - Pollution & Treatment Controls | Chemicals - Specialty |
| Market Cap | $1.57B | $207M | $498M | $493M |
| Revenue (TTM) | $1.98B | $59M | $127M | $174M |
| Net Income (TTM) | $31M | $-18M | $33M | $-11M |
| Gross Margin | 15.6% | 4.1% | 64.5% | 23.4% |
| Operating Margin | 6.3% | -26.3% | 24.1% | -4.6% |
| Forward P/E | 25.0x | — | 22.9x | — |
| Total Debt | $1.95B | $4M | $9M | $168M |
| Cash & Equiv. | $72M | $12M | $48M | $1M |
AMRC vs PESI vs ERII vs GEVO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ameresco, Inc. (AMRC) | 100 | 138.3 | +38.3% |
| Perma-Fix Environme… (PESI) | 100 | 199.8 | +99.8% |
| Energy Recovery, In… (ERII) | 100 | 122.7 | +22.7% |
| Gevo, Inc. (GEVO) | 100 | 157.4 | +57.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMRC vs PESI vs ERII vs GEVO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMRC is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 5.4% 10Y total return vs PESI's 178.6%
- +134.3% vs ERII's -37.3%
PESI lags the leaders in this set but could rank higher in a more targeted comparison.
ERII carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- beta 1.53
- Lower volatility, beta 1.53, Low D/E 4.6%, current ratio 10.44x
- Beta 1.53, current ratio 10.44x
- Better valuation composite
GEVO is the clearest fit if your priority is growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs ERII's -7.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs ERII's -7.1% | |
| Value | Better valuation composite | |
| Quality / Margins | 25.9% margin vs PESI's -30.1% | |
| Stability / Safety | Beta 1.53 vs AMRC's 2.03, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +134.3% vs ERII's -37.3% | |
| Efficiency (ROA) | 15.2% ROA vs PESI's -20.2%, ROIC 10.3% vs -21.7% |
AMRC vs PESI vs ERII vs GEVO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AMRC vs PESI vs ERII vs GEVO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ERII leads in 2 of 6 categories
AMRC leads 1 • GEVO leads 1 • PESI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ERII leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMRC is the larger business by revenue, generating $2.0B annually — 33.6x PESI's $59M. ERII is the more profitable business, keeping 25.9% of every revenue dollar as net income compared to PESI's -30.1%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.0B | $59M | $127M | $174M |
| EBITDAEarnings before interest/tax | $204M | -$14M | $41M | $18M |
| Net IncomeAfter-tax profit | $31M | -$18M | $33M | -$11M |
| Free Cash FlowCash after capex | -$251M | -$14M | $27M | -$35M |
| Gross MarginGross profit ÷ Revenue | +15.6% | +4.1% | +64.5% | +23.4% |
| Operating MarginEBIT ÷ Revenue | +6.3% | -26.3% | +24.1% | -4.6% |
| Net MarginNet income ÷ Revenue | +1.6% | -30.1% | +25.9% | -6.6% |
| FCF MarginFCF ÷ Revenue | -12.7% | -23.4% | +21.4% | -19.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.8% | -20.1% | -97.5% | +47.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.5% | -110.5% | +100.0% | +3.8% |
Valuation Metrics
AMRC leads this category, winning 2 of 5 comparable metrics.
Valuation Metrics
At 22.5x trailing earnings, ERII trades at a 37% valuation discount to AMRC's 35.8x P/E. On an enterprise value basis, AMRC's 15.0x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.6B | $207M | $498M | $493M |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $200M | $460M | $659M |
| Trailing P/EPrice ÷ TTM EPS | 35.76x | -14.89x | 22.45x | -14.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.04x | — | 22.91x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 15.00x | — | 16.23x | 102.12x |
| Price / SalesMarket cap ÷ Revenue | 0.81x | 3.36x | 3.70x | 3.07x |
| Price / BookPrice ÷ Book value/share | 1.41x | 4.11x | 2.48x | 1.01x |
| Price / FCFMarket cap ÷ FCF | — | — | 28.57x | — |
Profitability & Efficiency
ERII leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ERII delivers a 17.4% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-34 for PESI. ERII carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMRC's 1.73x. On the Piotroski fundamental quality scale (0–9), ERII scores 6/9 vs GEVO's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.9% | -34.5% | +17.4% | -2.4% |
| ROA (TTM)Return on assets | +0.7% | -20.2% | +15.2% | -1.7% |
| ROICReturn on invested capital | +3.3% | -21.7% | +10.3% | -2.8% |
| ROCEReturn on capital employed | +3.7% | -16.7% | +11.3% | -3.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 6 | 4 |
| Debt / EquityFinancial leverage | 1.73x | 0.09x | 0.05x | 0.36x |
| Net DebtTotal debt minus cash | $1.9B | -$7M | -$39M | $166M |
| Cash & Equiv.Liquid assets | $72M | $12M | $48M | $1M |
| Total DebtShort + long-term debt | $1.9B | $4M | $9M | $168M |
| Interest CoverageEBIT ÷ Interest expense | 1.20x | -42.14x | — | -0.04x |
Total Returns (Dividends Reinvested)
GEVO leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PESI five years ago would be worth $14,563 today (with dividends reinvested), compared to $3,476 for GEVO. Over the past 12 months, AMRC leads with a +134.3% total return vs ERII's -37.3%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs ERII's -26.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -3.2% | -8.8% | -31.3% | -1.5% |
| 1-Year ReturnPast 12 months | +134.3% | +26.2% | -37.3% | +88.0% |
| 3-Year ReturnCumulative with dividends | -29.9% | +21.7% | -60.0% | +65.0% |
| 5-Year ReturnCumulative with dividends | -44.0% | +45.6% | -54.3% | -65.2% |
| 10-Year ReturnCumulative with dividends | +542.4% | +178.6% | -11.9% | -98.6% |
| CAGR (3Y)Annualised 3-year return | -11.2% | +6.8% | -26.3% | +18.2% |
Risk & Volatility
Evenly matched — ERII and GEVO each lead in 1 of 2 comparable metrics.
Risk & Volatility
ERII is the less volatile stock with a 1.53 beta — it tends to amplify market swings less than AMRC's 2.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GEVO currently trades 68.4% from its 52-week high vs ERII's 51.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.03x | 1.85x | 1.53x | 1.64x |
| 52-Week HighHighest price in past year | $44.93 | $16.50 | $18.32 | $2.97 |
| 52-Week LowLowest price in past year | $12.37 | $8.02 | $9.30 | $1.01 |
| % of 52W HighCurrent price vs 52-week peak | +66.1% | +67.7% | +51.5% | +68.4% |
| RSI (14)Momentum oscillator 0–100 | 68.0 | 41.5 | 60.6 | 53.5 |
| Avg Volume (50D)Average daily shares traded | 507K | 164K | 996K | 4.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: AMRC as "Buy", PESI as "Hold", ERII as "Buy", GEVO as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs 37.9% for ERII (target: $13).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $43.17 | $18.00 | $13.00 | $3.50 |
| # AnalystsCovering analysts | 23 | 1 | 16 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +7.2% | 0.0% |
ERII leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AMRC leads in 1 (Valuation Metrics). 1 tied.
AMRC vs PESI vs ERII vs GEVO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AMRC or PESI or ERII or GEVO a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -7. 1% for Energy Recovery, Inc. (ERII). Energy Recovery, Inc. (ERII) offers the better valuation at 22. 5x trailing P/E (22. 9x forward), making it the more compelling value choice. Analysts rate Ameresco, Inc. (AMRC) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMRC or PESI or ERII or GEVO?
On trailing P/E, Energy Recovery, Inc.
(ERII) is the cheapest at 22. 5x versus Ameresco, Inc. at 35. 8x. On forward P/E, Energy Recovery, Inc. is actually cheaper at 22. 9x.
03Which is the better long-term investment — AMRC or PESI or ERII or GEVO?
Over the past 5 years, Perma-Fix Environmental Services, Inc.
(PESI) delivered a total return of +45. 6%, compared to -65. 2% for Gevo, Inc. (GEVO). Over 10 years, the gap is even starker: AMRC returned +542. 4% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMRC or PESI or ERII or GEVO?
By beta (market sensitivity over 5 years), Energy Recovery, Inc.
(ERII) is the lower-risk stock at 1. 53β versus Ameresco, Inc. 's 2. 03β — meaning AMRC is approximately 33% more volatile than ERII relative to the S&P 500. On balance sheet safety, Energy Recovery, Inc. (ERII) carries a lower debt/equity ratio of 5% versus 173% for Ameresco, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMRC or PESI or ERII or GEVO?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -7. 1% for Energy Recovery, Inc. (ERII). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -22. 4% for Ameresco, Inc.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMRC or PESI or ERII or GEVO?
Energy Recovery, Inc.
(ERII) is the more profitable company, earning 17. 0% net margin versus -22. 3% for Perma-Fix Environmental Services, Inc. — meaning it keeps 17. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ERII leads at 18. 2% versus -19. 0% for PESI. At the gross margin level — before operating expenses — ERII leads at 65. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMRC or PESI or ERII or GEVO more undervalued right now?
On forward earnings alone, Energy Recovery, Inc.
(ERII) trades at 22. 9x forward P/E versus 25. 0x for Ameresco, Inc. — 2. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEVO: 72. 4% to $3. 50.
08Which pays a better dividend — AMRC or PESI or ERII or GEVO?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is AMRC or PESI or ERII or GEVO better for a retirement portfolio?
For long-horizon retirement investors, Energy Recovery, Inc.
(ERII) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ERII: -11. 9%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMRC and PESI and ERII and GEVO?
These companies operate in different sectors (AMRC (Industrials) and PESI (Industrials) and ERII (Industrials) and GEVO (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AMRC is a small-cap quality compounder stock; PESI is a small-cap quality compounder stock; ERII is a small-cap quality compounder stock; GEVO is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.